Dr. Julian Prosia is an optometrist and leading innovator in amniotic membrane therapy in Canada. Known for his expertise in Dry Eye and Ocular surface disease management, he introduced Canada’s first doctor-owned amniotic membrane company, Ophthalogix Canada, to expand national access to advanced ocular treatments. Over his career, Dr. Prosia has performed more than 2,000 amniotic membrane procedures and managed over 50,000 Dry Eye cases. A respected speaker, educator, and social media voice in the eye care community, he continues to shape the future of ocular surface disease management through clinical excellence, education, and innovation.